About Us
Zurex Pharma, Inc. is a specialty pharma and medical technology company with a novel antimicrobial technology platform. Our company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections.
At Zurex Pharma, we have assembled a team of experienced professionals with a solid track record of product development and commercialization.
Management
- Carmine J. Durham, President and CEO
- Michael C. Pawlak, Director of Agricultural Operations
- R. Andrew Morgan, Executive Vice President
Management Partners
- Mary Phillips-Coyle, Interim Chief Financial Officer
- Catherine Joy, Controller, Accede CPA
- Makin' Hey, Marketing Communications
- DeVere Chemical, Prod. Development and Manufacturing
- AlphaTech Counsel, General Legal Counsel
- Foley & Lardner, General Legal Counsel
- Leydig, Voit & Mayer, Intellectual Property
- Peak Ridge Capital, Corporate Partner
Directors
- Robert B. Truitt, Chairman
- Stephen R. Ash, MD
- Joseph H. Broecker
- Lorelei D. Davis, PhD
- Carmine J. Durham, President and CEO
- Adel Korkor, MD
- Gary J. Lehman
- Dominick Treschitta
- Norman R. Weldon, PhD
Associations
New Ag Products
ZuraLac™ is specifically formulated to sanitize and protect teats from mastitis causing organisms, and protect teat skin tissue from harsh environmental conditions.
Contact
Zurex Pharma's corporate office is located in the University Research Park of Madison, Wisconsin. Specific comments or questions may be submitted online through our contact page.
